Signet-ring cell adenocarcinoma of sinonasal tract: An immunohistochemical study of the mucins profile

Archives of Pathology and Laboratory Medicine

Volumn 131, Issue 6, 2007, Pages 961-964

  Castillo, Christine ^a   Buob, David ^a   Mortuaire, Geoffrey ^a   Chevalier, Dominique ^a   Aubert, Sebastien ^a   Copin, Marie Christine ^a   Leroy, Xavier ^a  

^a LILLE UNIVERSITY HOSPITAL   (France)

Author keywords

[No Author keywords available]

Indexed keywords

KI 67 ANTIGEN; MONOCLONAL ANTIBODY; MUCIN; MUCIN 2; MUCIN 5AC; MUCIN 5B; MUCIN 6; PROTEIN P53;

AGED; ARTICLE; CANCER GRADING; CASE REPORT; CAUSE OF DEATH; CLINICAL FEATURE; FEMALE; FOLLOW UP; GASTROINTESTINAL CARCINOMA; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MALE; METASTASIS; MORPHOLOGY; NOSE CAVITY; SIGNET RING CARCINOMA; TISSUE SECTION; TREATMENT INDICATION; TREATMENT OUTCOME; TUMOR CELL;

AGED; AGED, 80 AND OVER; CARCINOMA, SIGNET RING CELL; COMBINED MODALITY THERAPY; FATAL OUTCOME; HUMANS; IMMUNOENZYME TECHNIQUES; KI-67 ANTIGEN; MALE; MUCINS; PARANASAL SINUS NEOPLASMS; TUMOR MARKERS, BIOLOGICAL; TUMOR SUPPRESSOR PROTEIN P53;

EID: 34250158782     PISSN: 00039985     EISSN: 15432165     Source Type: Journal    
DOI: None     Document Type: Article

References (23)

1. Kleinsasser O, Schroeder H-G. Adenocarcinomas of the inner nose after exposure to wood dust. Arch Otorhinolaryngol. 1988;245:1-15.
2. Batsakis J, Holtz F, Sueper R, Arbor A. Adenocarcinoma of nasal and paranasal cavities. Arch Otorhinolaryngol. 1963;77:625-633.
3. Franquemont D, Fechner R, Mills S. Histologic classification of sinonasal intestinal-type adenocarcinoma. Am J Surg Pathol. 1991;15:368-375.
4. Vernet JL, Kennel P, Piller P, Methlin A, Walter P, Conraux C. Intestinal type adenocarcinoma of the nasal fossae and sinuses: histological classification, clinical aspects and pronostic assessment. Rev Laryngol Otol Rhinol. 1994;115:107-112.
5. Franchi A, Gallo O, Santucci M. Clinical relevance of the histological classification of sinonasal intestinal-type adenocarcinomas. Human Pathol. 1999;30:1140-1145.
6. Abecassis J, Viana G, Pissara C, Pereira T, Fonseca I, Soares J. Adenocarcinomas of the nasal cavity and paranasal sinuses: a clinical and immunohistochemical study of 14 cases. Histopathology. 2004;45:254-259.
7. Herrmann A, Davies JR, Lindell G, et al. Studies on the "insoluble" glycoprotein complex from human colon: identification of reduction-insensitive MUC2 oligomers and C-terminal cleavage. J Biol Chem. 1999;274:15828-15836.
8. Rousseau K, Wickstrom C, Whitehouse DB, Carlstedt I, Swallow DM. New monoclonal antibodies to non-glycosylated domains of the secreted mucins MUC5B and MUC7. Hybrid Hybridomics. 2003;22:293-299.
9. Barker BF. Odontogenic myxoma. Semin Diagn Pathol. 1999;16:297-301.
10. Moshiri S, Oda D, Worthington P, Myall R. Odontogenic myxoma: histochemical and ultrastructural study. J Oral Pathol Med. 1992;21:401-403.
11. Tanaka K. A case of metastasis to the paranasal sinuses from rectal mucinous adenocarcinoma. Int J Clin Oncol. 2006;11:64-65.
12. Ortiz-Rev JA, Alvarez C, San Miguel P, Iglesias B, Anton I. Expression of CDX2, cytokeratins 7 and 20 in sinonasal intestinal-type adenocarcinoma. Appl Immunohistochem Mol Morphol. 2005;13:142-146.
13. Resto VA, Krane JF, Faquin WC, Lin DT. Immunohistochemical distinction of intestinal-type sinonasal adenocarcinoma from metastatic adenocarcinoma of intestinal origin. Ann Otol Rhinol Laryngol. 2006;115:59-64.
14. Copin MC, Buisine MP, Leteurtre E, et al. Mucinous bronchioloalveolar carcinomas display a specificc pattern of mucin gene expression among primary lung adenocarcinomas. Human Pathol. 2001;32:274-281.
15. Byrd JC, Bresalier RS. Mucins and mucin binding proteins in colorectal cancer. J Gastroenterol. 2004;39:125-132.
16. Ishizu H, Kumagai J, Eishi Y, Takizawa T, Koike M. Mucin core protein expression by colorectal mucinous carcinomas with or without mucus hyperplasia. J Gastroenterol. 2004;39:125-132.
17. Flucke U, Steinborn E, Dries V, et al. Immunoreactivity of cytokeratins (CK7, CK20) and mucin peptide core antigens (MUC1, MUC2, MUC5AC) in adenocarcinomas, normal and metaplastic tissues of the distal oesophagus, oesophago-gastric junction and proximal stomach. Histopathology. 2003;43:127-134.
18. Chu PG, Weiss LM. Immunohistochemical characterization of signet-ring cell carcinomas of the stomach, breast, and colon. Am J Clin Pathol. 2004;121:884-892.
19. Zhang HK, Zhang QM, Zhao TH, Li YY, Yi YF. Expression of mucins and E-cadherin in gastric carcinoma and their clinical significance. World J Gastroenterol. 2004;10:3044-3047.
20. Akyurek N, Akyol G, Dursun A, Yamac D, Gunel N. Expression of MUC1 and MUC2 mucins in gastric carcinomas: their relationship with clinicopathologic parameters and prognosis. Pathol Res Pract. 2002;198:665-674.
21. Losi L, Scarselli A, Benatti P, et al. Relationship between MUC5AC and altered expression of MLH1 protein in mucinous and non-mucinous colorectal carcinomas. Pathol Res Pract. 2004;200:371-377.
22. Nguyen MD, Plasil B, Wen P, Frankel WL. Mucin profiles in signet-ring cell carcinoma. Arch Pathol Lab Med. 2006;130:799-804.
23. Park IJ, Kim HC, Kim JS, Yu ES, Yu CS, Kim JC. Correlation between hMLH1/hMSH2 and p53 protein expression in sporadic colorectal cancer. Hepatogastroenterology. 2005;52:450-454.